Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy
Clinical trial NCT03755791 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03755791
- Sponsor
- Exelixis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-10
- Primary completion
- 2021-11-30
- Enrollment
- 837
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.